We are excited to announce that the Resilix® adherence software application and platform is a finalist for the 2020 CPhI Pharma Awards in the Digital Innovation category!
Improving adherence requires software that is designed specifically with patient needs in mind. As a purpose-built adherence application, Resilix helps brands provide better, more personalized, patient support resulting in higher initiation and adherence, and an improved patient experience. We are proud of the recognition of Resilix and its role in helping patients throughout their treatment journey.
Congratulations to all nominees, and we look forward to grand finale on October 13th.
Human Care Systems Named a Finalist for the 2020 CPhI Pharma Awards
Subscribe today to get the latest updates
Related Posts

Human Care Systems Named One of the Most Innovative Companies of 2019 by PM360
Jessica Lens
/ Dec 13, 2019
BOSTON (December 13, 2019) — We’re happy to announce that we’ve been chosen as one of PM360’s most innovative companies in 2019. Our work launching Resilix caught the attention of the PM360 editors,...

Almost any company with a specialty pharmaceutical to market includes an internal or outsourced patient-support service, and almost any such service needs an IT platform to track interactions and...

Human Care Systems Releases Version 5.0 of Resilix® Treatment Experience Platform
Human Care Systems
/ Nov 05, 2019
Human Care Systems, developer of Resilix®, a treatment experience platform designed specifically for pharmaceutical manufacturers to provide better patient services and support, today announced the...